1492 Capital Management’s EnteroMedics Inc. ETRM Stock Holding History

1492 Capital Management’s Portfolio ETRM Stock Details ETRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-170	Closed	-$254K	–	162
2014 Q4	$254K	Sell	170 -11	-6%	-$14.9K	0.16%	104
2014 Q3	$234K	Sell	181 -13	-7%	-$19.1K	0.13%	102
2014 Q2	$318K	Sell	194 -108	-36%	-$202K	0.16%	91
2014 Q1	$577K	Buy	302 +30	+11%	+$71K	0.29%	88
2013 Q4	$584K	Buy	+272	New	+$438K	0.31%	82

Other funds holding ETRM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IHM

Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Bailard Foster City, California $4.35B AUM 23.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCCM

Blue Clay Capital Management Minneapolis, Minnesota $88.7M AUM 6.88% 1-Year Est. Return

1492 Capital Management's ETRM Position: Q1 2015 in Review

1492 Capital Management sold out of EnteroMedics Inc. (ETRM) in Q1 2015, closing a stake of 170 shares — an estimated $254K sold.

1492 Capital Management first reported a position in ETRM in Q4 2013 and held it in 5 quarters. The position peaked at $584K in Q4 2013. 51 funds tracked by Wall St. Rank hold ETRM as of Q1 2015.

1492 Capital Management reported no remaining EnteroMedics Inc. position as of Q1 2015 after selling out during the quarter.
1492 Capital Management sold 170 EnteroMedics Inc. shares in Q1 2015, an estimated $254K.
1492 Capital Management first reported a position in EnteroMedics Inc. in Q4 2013 and held it in 5 quarters.
1492 Capital Management's EnteroMedics Inc. position peaked at $584K in Q4 2013.
51 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q1 2015.

Based on 1492 Capital Management's 13F filing for Q1 2015, filed 13 May 2015.